What is the current annual EBITDA of ALGN?

As of today, ALGN annual EBITDA is $851.39M

What is 1-year change in ALGN annual EBITDA?

ALGN annual EBITDA is up +4.23% year-over-year

What is 3-year change in ALGN annual EBITDA?

ALGN annual EBITDA is up +5.06% over the past 3 years

How far is ALGN annual EBITDA from its all-time high?

ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on December 31, 2021

How does ALGN annual EBITDA rank versus sector peers?

ALGN annual EBITDA is higher than 92.54% of companies in Healthcare sector

When is ALGN next annual earnings release?

As of today, the next annual earnings release for ALGN has not been scheduled

What is the current quarterly EBITDA of ALGN?

As of today, ALGN quarterly EBITDA is $232.81M

What is ALGN quarterly EBITDA most recent change?

ALGN quarterly EBITDA was down -3.62% on June 30, 2026

What is 1-year change in ALGN quarterly EBITDA?

ALGN quarterly EBITDA is up +14.34% year-over-year

How far is ALGN quarterly EBITDA from its all-time high?

ALGN quarterly EBITDA is currently -22.73% below its historical high of $301.30M set on June 30, 2021

How does ALGN quarterly EBITDA rank versus sector peers?

ALGN quarterly EBITDA is higher than 92.18% of companies in Healthcare sector

When is ALGN next earnings release?

The next earnings release for ALGN is on October 28, 2026

What is the current TTM EBITDA of ALGN?

As of today, ALGN TTM EBITDA is $947.74M

What is ALGN TTM EBITDA most recent change?

ALGN TTM EBITDA was up +3.18% on June 30, 2026

What is 1-year change in ALGN TTM EBITDA?

ALGN TTM EBITDA is up +19.45% year-over-year

How far is ALGN TTM EBITDA from its all-time high?

ALGN TTM EBITDA is currently -14.71% below its historical high of $1.11B set on December 31, 2021

How does ALGN TTM EBITDA rank versus sector peers?

ALGN TTM EBITDA is higher than 92.56% of companies in Healthcare sector

When is ALGN next earnings release?

The next earnings release for ALGN is on October 28, 2026

ALGN EBITDA History & Chart Since 1997

Annual EBITDA

$851.39M$34.59M+4.23%

December 31, 2025

Summary

Current Value: As of today, ALGN annual EBITDA is $851.39M, up +4.23% on December 31, 2025
Historical Performance: ALGN annual EBITDA is up +5.06% over the past 3 years, up +69.22% over the past 5 years
All-Time High Comparison: ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on December 31, 2021
3-Year Low Comparison: ALGN annual EBITDA is +6.55% above its 3-year low of $799.06M reached on December 31, 2023
Sector Comparison: ALGN annual EBITDA is higher than 92.54% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

ALGN Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$851.39M	+4.2%	+5.1%	+69.2%	+654.8%
Quarterly EBITDA	Jun 30, 26	$232.81M	+14.3%	+8.0%	-22.7%	+734.4%
TTM EBITDA	Jun 30, 26	$947.74M	+19.4%	+27.8%	-6.1%	+827.6%
Price	Aug 12, 26	$174.02	+23.9%	-50.7%	-75.3%	+837.1%
PE Ratio	Aug 12, 26	30.19	+27.4%	-65.2%	-62.4%	+12.2%
Annual Revenue	Dec 31, 25	$4.03B	+0.9%	+8.0%	+63.2%	+942.3%
Annual EPS	Dec 31, 25	$5.65	+0.6%	+22.6%	-74.8%	+495.1%
	Dec 31, 25	$616.22M	-8.3%	-5.8%	+59.2%	+524.9%
Annual Net Income	Dec 31, 25	$410.35M	-2.6%	+13.5%	-76.9%	+452.6%

EBITDA Highs

ALGN Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$851.39M	Dec 31, 25	at high
5Y	$1.11B	Dec 31, 21	-23.4%
All	$1.11B	Dec 31, 21	-23.4%

EBITDA Lows

ALGN Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$799.06M	Dec 31, 23	+6.5%
5Y	$503.14M	N/A	+69.2%
All	-$90.85M	Dec 31, 01	+1037.1%

EBITDA History

Year	Value	Change
2025	$851.39M	+4.2%
2024	$816.80M	+2.2%
2023	$799.06M	-1.4%
2022	$810.37M	-27.1%
2021	$1.11B	+121.0%
2020	$503.14M	-18.6%
2019	$617.86M	+18.5%
2018	$521.29M	+33.2%
2017	$391.35M	+43.4%
2016	$272.92M	+32.1%
2015	$206.64M	-2.3%
2014	$211.43M	+17.6%
2013	$179.75M	+27.7%
2012	$140.79M	+17.2%
2011	$120.14M	+6.5%

Year	Value	Change
2010	$112.80M	+125.7%
2009	$49.98M	+37.9%
2008	$36.24M	-20.3%
2007	$45.44M	+451.7%
2006	-$12.92M	-161.8%
2005	$20.90M	-6.6%
2004	$22.36M	+372.1%
2003	-$8.22M	+83.5%
2002	-$49.89M	+45.1%
2001	-$90.85M	-15.6%
2000	-$78.60M	-455.6%
1999	-$14.15M	-268.8%
1998	-$3.84M	-470.8%
1997	-$672.00K	-

FAQ

What is the current annual EBITDA of ALGN?: As of today, ALGN annual EBITDA is $851.39M
What is 1-year change in ALGN annual EBITDA?: ALGN annual EBITDA is up +4.23% year-over-year
What is 3-year change in ALGN annual EBITDA?: ALGN annual EBITDA is up +5.06% over the past 3 years
How far is ALGN annual EBITDA from its all-time high?: ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on December 31, 2021
How does ALGN annual EBITDA rank versus sector peers?: ALGN annual EBITDA is higher than 92.54% of companies in Healthcare sector
When is ALGN next annual earnings release?: As of today, the next annual earnings release for ALGN has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$232.81M$8.75M-3.62%

June 30, 2026

Summary

Current Value: As of today, ALGN quarterly EBITDA is $232.81M, down -3.62% on June 30, 2026
Historical Performance: ALGN quarterly EBITDA is up +14.34% year-over-year, up +8.02% over the past 3 years
All-Time High Comparison: ALGN quarterly EBITDA is currently -22.73% below its historical high of $301.30M set on June 30, 2021
3-Year Low Comparison: ALGN quarterly EBITDA is +33.47% above its 3-year low of $174.43M reached on March 31, 2025
Sector Comparison: ALGN quarterly EBITDA is higher than 92.18% of companies in Healthcare sector

Performance

ALGN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 30, 26	$232.81M	-3.6%	+14.3%	+8.0%	-22.7%
Annual EBITDA	Dec 31, 25	$851.39M	–	+4.2%	+5.1%	+69.2%
TTM EBITDA	Jun 30, 26	$947.74M	+3.2%	+19.4%	+27.8%	-6.1%
Price	Aug 12, 26	$174.02	+5.0%	+23.9%	-50.7%	-75.3%
PE Ratio	Aug 12, 26	30.19	+8.6%	+27.4%	-65.2%	-62.4%
Quarterly Revenue	Jun 30, 26	$1.06B	+1.6%	+4.3%	+5.4%	+4.5%
Quarterly EPS	Jun 30, 26	$1.51	-3.8%	-11.8%	+3.9%	-39.6%
	Jun 30, 26	$192.73M	+4.2%	+18.2%	+12.1%	-28.3%
Quarterly Net Income	Jun 30, 26	$108.29M	-4.0%	-13.1%	-3.1%	-45.8%

Quarterly EBITDA Highs

ALGN Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$261.59M	Dec 31, 25	-11.0%
3Y	$261.59M	Dec 31, 25	-11.0%
5Y	$301.30M	N/A	-22.7%
All	$301.30M	Jun 30, 21	-22.7%

Quarterly EBITDA Lows

ALGN Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$203.61M	N/A	+14.3%
3Y	$174.43M	Mar 31, 25	+33.5%
5Y	$165.58M	Dec 31, 22	+40.6%
All	-$43.85M	Jun 30, 20	+630.9%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	$232.81M	-3.6%
Mar 2026	$241.56M	-7.7%
Dec 2025	$261.59M	+23.5%
Sep 2025	$211.78M	+4.0%
Jun 2025	$203.61M	+16.7%
Mar 2025	$174.43M	-19.0%
Dec 2024	$215.22M	+7.5%
Sep 2024	$200.16M	-6.6%
Jun 2024	$214.34M	+14.6%
Mar 2024	$187.08M	-14.3%
Dec 2023	$218.23M	+7.3%
Sep 2023	$203.38M	-5.6%
Jun 2023	$215.53M	+21.7%
Mar 2023	$177.09M	+7.0%
Dec 2022	$165.58M	-9.8%
Sep 2022	$183.53M	-18.8%
Jun 2022	$226.03M	-3.9%
Mar 2022	$235.23M	-8.5%
Dec 2021	$257.23M	-13.0%
Sep 2021	$295.73M	-1.8%
Jun 2021	$301.30M	+17.2%
Mar 2021	$256.99M	+5.5%
Dec 2020	$243.56M	+17.5%
Sep 2020	$207.23M	+572.5%
Jun 2020	-$43.85M	-145.6%
Mar 2020	$96.20M	-45.9%
Dec 2019	$177.82M	+27.0%
Sep 2019	$140.07M	-6.0%
Jun 2019	$148.98M	+6.3%
Mar 2019	$140.16M	+2.3%
Dec 2018	$137.02M	-1.7%
Sep 2018	$139.33M	+3.0%
Jun 2018	$135.32M	+23.4%
Mar 2018	$109.63M	-9.1%
Dec 2017	$120.63M	+10.9%
Sep 2017	$108.74M	+17.6%
Jun 2017	$92.45M	+32.9%
Mar 2017	$69.54M	-8.0%
Dec 2016	$75.59M	+9.6%
Sep 2016	$68.98M	-1.8%
Jun 2016	$70.23M	+20.8%
Mar 2016	$58.13M	-9.5%
Dec 2015	$64.20M	+50.9%
Sep 2015	$42.55M	-8.8%
Jun 2015	$46.66M	-12.4%
Mar 2015	$53.23M	-4.7%
Dec 2014	$55.88M	-0.0%
Sep 2014	$55.89M	+5.3%
Jun 2014	$53.09M	+14.0%
Mar 2014	$46.58M	-18.4%
Dec 2013	$57.10M	+26.0%
Sep 2013	$45.32M	+8.6%

Month	Value	Change
Jun 2013	$41.75M	+23.2%
Mar 2013	$33.88M	-1.1%
Dec 2012	$34.26M	+1.5%
Sep 2012	$33.76M	-16.4%
Jun 2012	$40.36M	+24.6%
Mar 2012	$32.41M	+5.6%
Dec 2011	$30.70M	-9.3%
Sep 2011	$33.84M	+21.3%
Jun 2011	$27.90M	+6.5%
Mar 2011	$26.20M	+35.1%
Dec 2010	$19.40M	-32.3%
Sep 2010	$28.67M	-29.0%
Jun 2010	$40.40M	+66.0%
Mar 2010	$24.34M	+35.4%
Dec 2009	$17.97M	+40.6%
Sep 2009	$12.78M	+29.1%
Jun 2009	$9.90M	+6.0%
Mar 2009	$9.34M	-9.9%
Dec 2008	$10.37M	-7.0%
Sep 2008	$11.15M	+58.6%
Jun 2008	$7.03M	-8.5%
Mar 2008	$7.69M	-4.6%
Dec 2007	$8.06M	-31.3%
Sep 2007	$11.73M	-31.2%
Jun 2007	$17.05M	+98.3%
Mar 2007	$8.60M	+1,766.9%
Dec 2006	-$516.00K	+94.1%
Sep 2006	-$8.69M	-1,032.0%
Jun 2006	-$768.00K	+73.9%
Mar 2006	-$2.94M	-141.2%
Dec 2005	$7.14M	+149.1%
Sep 2005	$2.87M	-24.2%
Jun 2005	$3.78M	-23.0%
Mar 2005	$4.91M	+3.9%
Dec 2004	$4.73M	-22.9%
Sep 2004	$6.13M	-5.8%
Jun 2004	$6.51M	+109.9%
Mar 2004	$3.10M	-17.6%
Dec 2003	$3.76M	+143.3%
Sep 2003	$1.55M	+126.4%
Jun 2003	-$5.85M	+7.0%
Mar 2003	-$6.29M	+41.5%
Dec 2002	-$10.74M	+15.3%
Sep 2002	-$12.68M	+17.8%
Jun 2002	-$15.43M	+2.9%
Mar 2002	-$15.89M	+13.9%
Dec 2001	-$18.46M	+12.3%
Sep 2001	-$21.05M	+1.8%
Jun 2001	-$21.42M	+28.4%
Mar 2001	-$29.93M	+12.2%
Dec 2000	-$34.07M	-340.5%
Mar 2000	-$7.74M	-

FAQ

What is the current quarterly EBITDA of ALGN?: As of today, ALGN quarterly EBITDA is $232.81M
What is ALGN quarterly EBITDA most recent change?: ALGN quarterly EBITDA was down -3.62% on June 30, 2026
What is 1-year change in ALGN quarterly EBITDA?: ALGN quarterly EBITDA is up +14.34% year-over-year
How far is ALGN quarterly EBITDA from its all-time high?: ALGN quarterly EBITDA is currently -22.73% below its historical high of $301.30M set on June 30, 2021
How does ALGN quarterly EBITDA rank versus sector peers?: ALGN quarterly EBITDA is higher than 92.18% of companies in Healthcare sector
When is ALGN next earnings release?: The next earnings release for ALGN is on October 28, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$947.74M$29.20M+3.18%

June 30, 2026

Summary

Current Value: As of today, ALGN TTM EBITDA is $947.74M, up +3.18% on June 30, 2026
Historical Performance: ALGN TTM EBITDA is up +19.45% year-over-year, up +27.78% over the past 3 years
All-Time High Comparison: ALGN TTM EBITDA is currently -14.71% below its historical high of $1.11B set on December 31, 2021
3-Year Low Comparison: ALGN TTM EBITDA is +27.78% above its 3-year low of $741.73M reached on an earlier date
Sector Comparison: ALGN TTM EBITDA is higher than 92.56% of companies in Healthcare sector

Performance

ALGN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 30, 26	$947.74M	+3.2%	+19.4%	+27.8%	-6.1%
Annual EBITDA	Dec 31, 25	$851.39M	–	+4.2%	+5.1%	+69.2%
Quarterly EBITDA	Jun 30, 26	$232.81M	-3.6%	+14.3%	+8.0%	-22.7%
Price	Aug 12, 26	$174.02	+5.0%	+23.9%	-50.7%	-75.3%
PE Ratio	Aug 12, 26	30.19	+8.6%	+27.4%	-65.2%	-62.4%
TTM Revenue	Jun 30, 26	$4.14B	+1.1%	+4.4%	+10.8%	+19.1%
TTM EPS	Jun 30, 26	$5.76	-3.4%	-2.8%	+41.9%	-34.3%
	Jun 30, 26	$760.90M	+4.1%	+19.3%	+32.7%	-14.0%
TTM Net Income	Jun 30, 26	$413.58M	-3.8%	-5.5%	+31.7%	-40.8%

TTM EBITDA Highs

ALGN TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$947.74M	Jun 30, 26	at high
3Y	$947.74M	Jun 30, 26	at high
5Y	$1.11B	Dec 31, 21	-14.7%
All	$1.11B	Dec 31, 21	-14.7%

TTM EBITDA Lows

ALGN TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$793.41M	N/A	+19.4%
3Y	$741.73M	N/A	+27.8%
5Y	$741.73M	Jun 30, 23	+27.8%
All	-$106.47M	Sep 30, 01	+990.1%

TTM EBITDA History

Month	Value	Change
Jun 2026	$947.74M	+3.2%
Mar 2026	$918.54M	+7.9%
Dec 2025	$851.41M	+5.8%
Sep 2025	$805.04M	+1.5%
Jun 2025	$793.41M	-1.3%
Mar 2025	$804.14M	-1.5%
Dec 2024	$816.80M	-0.4%
Sep 2024	$819.81M	-0.4%
Jun 2024	$823.03M	-0.1%
Mar 2024	$824.22M	+1.2%
Dec 2023	$814.23M	+6.9%
Sep 2023	$761.58M	+2.7%
Jun 2023	$741.73M	-1.4%
Mar 2023	$752.23M	-7.2%
Dec 2022	$810.37M	-10.2%
Sep 2022	$902.01M	-11.1%
Jun 2022	$1.01B	-6.9%
Mar 2022	$1.09B	-2.0%
Dec 2021	$1.11B	+1.2%
Sep 2021	$1.10B	+8.8%
Jun 2021	$1.01B	+52.0%
Mar 2021	$663.93M	+32.0%
Dec 2020	$503.14M	+15.0%
Sep 2020	$437.40M	+18.1%
Jun 2020	$370.24M	-34.2%
Mar 2020	$563.07M	-7.2%
Dec 2019	$607.03M	+7.2%
Sep 2019	$566.22M	+0.1%
Jun 2019	$565.48M	+2.5%
Mar 2019	$551.83M	+5.9%
Dec 2018	$521.29M	+3.2%
Sep 2018	$504.91M	+6.4%
Jun 2018	$474.31M	+9.9%
Mar 2018	$431.44M	+10.2%
Dec 2017	$391.35M	+13.0%
Sep 2017	$346.31M	+13.0%
Jun 2017	$306.55M	+7.8%
Mar 2017	$284.34M	+4.2%
Dec 2016	$272.92M	+4.4%
Sep 2016	$261.54M	+11.2%
Jun 2016	$235.11M	+11.1%
Mar 2016	$211.53M	+2.4%
Dec 2015	$206.64M	+4.2%
Sep 2015	$198.32M	-6.3%
Jun 2015	$211.65M	-2.9%
Mar 2015	$218.08M	+3.1%
Dec 2014	$211.43M	-0.6%
Sep 2014	$212.65M	+5.2%
Jun 2014	$202.09M	+5.9%
Mar 2014	$190.75M	+7.1%
Dec 2013	$178.05M	+14.7%
Sep 2013	$155.21M	+8.0%

Month	Value	Change
Jun 2013	$143.65M	+1.0%
Mar 2013	$142.27M	+1.0%
Dec 2012	$140.79M	+2.6%
Sep 2012	$137.23M	-0.1%
Jun 2012	$137.30M	+10.0%
Mar 2012	$124.84M	+5.2%
Dec 2011	$118.64M	+10.5%
Sep 2011	$107.34M	+5.1%
Jun 2011	$102.18M	-10.9%
Mar 2011	$114.67M	+1.7%
Dec 2010	$112.80M	+1.3%
Sep 2010	$111.37M	+16.6%
Jun 2010	$95.48M	+46.9%
Mar 2010	$64.98M	+30.0%
Dec 2009	$49.98M	+17.9%
Sep 2009	$42.38M	+4.0%
Jun 2009	$40.75M	+7.6%
Mar 2009	$37.89M	+4.6%
Dec 2008	$36.24M	+6.8%
Sep 2008	$33.93M	-1.7%
Jun 2008	$34.51M	-22.5%
Mar 2008	$44.53M	-2.0%
Dec 2007	$45.44M	+23.3%
Sep 2007	$36.87M	+124.2%
Jun 2007	$16.44M	+1,294.2%
Mar 2007	-$1.38M	+89.3%
Dec 2006	-$12.92M	-145.4%
Sep 2006	-$5.27M	-183.6%
Jun 2006	$6.30M	-41.9%
Mar 2006	$10.85M	-42.0%
Dec 2005	$18.70M	+14.8%
Sep 2005	$16.28M	-16.7%
Jun 2005	$19.54M	-12.2%
Mar 2005	$22.27M	+8.8%
Dec 2004	$20.46M	+4.9%
Sep 2004	$19.50M	+30.7%
Jun 2004	$14.92M	+482.9%
Mar 2004	$2.56M	+137.5%
Dec 2003	-$6.83M	+68.0%
Sep 2003	-$21.33M	+40.0%
Jun 2003	-$35.55M	+21.2%
Mar 2003	-$45.13M	+17.5%
Dec 2002	-$54.73M	+12.4%
Sep 2002	-$62.45M	+11.8%
Jun 2002	-$70.82M	+7.8%
Mar 2002	-$76.81M	+15.5%
Dec 2001	-$90.85M	+14.7%
Sep 2001	-$106.47M	-24.6%
Jun 2001	-$85.42M	-33.5%
Mar 2001	-$64.00M	-53.1%
Dec 2000	-$41.81M	-440.5%
Mar 2000	-$7.74M	-

FAQ

What is the current TTM EBITDA of ALGN?: As of today, ALGN TTM EBITDA is $947.74M
What is ALGN TTM EBITDA most recent change?: ALGN TTM EBITDA was up +3.18% on June 30, 2026
What is 1-year change in ALGN TTM EBITDA?: ALGN TTM EBITDA is up +19.45% year-over-year
How far is ALGN TTM EBITDA from its all-time high?: ALGN TTM EBITDA is currently -14.71% below its historical high of $1.11B set on December 31, 2021
How does ALGN TTM EBITDA rank versus sector peers?: ALGN TTM EBITDA is higher than 92.56% of companies in Healthcare sector
When is ALGN next earnings release?: The next earnings release for ALGN is on October 28, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

ALGN Official Website www.aligntech.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1097149/000109714926000006/0001097149-26-000006-index.htm
ALGN Profile on Yahoo Finance finance.yahoo.com/quote/ALGN
ALGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/algn